Skip to main content
. 2023 Apr 4;15(7):2149. doi: 10.3390/cancers15072149

Table 3.

Cancer-specific survival-related gene expression signature.

Gene t-Test FDR AUC Optimal Cut-Off
HRAS <0.0001 <0.0001 0.80 2.48
CDKN1A <0.0001 <0.0001 0.80 3.4
MAP4K1 <0.0001 <0.0001 0.79 2.01
NFE2L2 <0.0001 <0.0001 0.79 3.43
TP53 <0.0001 <0.0001 0.84 3.06
FGF2 <0.0001 <0.0001 0.80 1.86
IDO1 <0.0001 0.0001 0.76 2.08
DAB2 <0.0001 0.0002 0.77 3.16
FGFR3 0.0001 0.0002 0.81 3.29
ANXA10 0.0003 0.0008 0.75 3.05
CCND1 0.0008 0.0020 0.76 3.77
AKT1 0.0011 0.0024 0.73 3.56
SPOCD1 0.0012 0.0025 0.74 2.87
ARID1A 0.0021 0.0041 0.68 2.93
MKI67 0.0023 0.0042 0.70 2.6
CCND3 0.0039 0.0065 0.71 2.71
BIRC3 0.0044 0.0070 0.68 2.28
VEGFA 0.0150 0.0225 0.66 3.72
STAG2 0.0173 0.0246 0.57 3.09

FDR: false discovery rate; AUC: Area under the ROC Curve; ROC Receiving operating characteristic.